10.29.15
Sherwin-Williams has announced the launch of Paint Shield, the first EPA-registered microbicidal paint that continuously kills these difficult-to-treat, infection-causing bacteria after two hours of exposure on painted surfaces.
By killing these infectious bacteria on painted surfaces, Paint Shield offers customers an important new tool to help prevent the spread of bacteria that can cause hospital-acquired infections (HAIs). Surfaces painted with Paint Shield kill greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycin-resistant Enterococcus faecalis) and Enterobacter aerogenes after two hours of exposure.
“Paint Shield is one of the most significant technological breakthroughs in our nearly 150 year history of innovation,” said Chris Connor, chairman and chief executive, Sherwin-Williams. “By killing infectious pathogens on painted surfaces, Paint Shield is a game-changing advancement in coatings technology.”
Paint Shield doesn’t just inhibit the growth of common microbes, it actually has the power to kill infectious bacteria, including Staph (Staphylococcus aureus), MRSA, and E. coli, thereby giving healthcare systems and other facilities an important new tool to help prevent the spread of some of the most common bacteria that trigger hospital-acquired infections. EPA-test protocol showed that once it is applied, the effectiveness of Paint Shield lasts for up to four years, as long as the integrity of the surface is maintained.
According to the U.S. Department of Health and Human Services, healthcare-associated infections are one of the leading causes of preventable deaths in the United States. Further, the U.S. Centers for Disease Control and Prevention (CDC) notes that approximately one in 25 U.S. patients contract at least one infection during the course of their hospital care.
“Continued progress in combating HAIs will require a broad array of measures, including passive methods that are less dependent on human intervention,” said Steve Revnew, senior vice president of Product Innovation, Sherwin-Williams. “By continuing to kill MRSA and other bacteria, even after repeated contamination, Paint Shield offers hospitals and other facilities an important new tool to help in the fight against the spread of HAIs.”
The exclusive patented technology in Paint Shield represents the culmination of extensive research and collaboration between Sherwin-Williams coatings scientists and expert microbiologists.
Paint Shield can be applied on interior hard, non-porous ceilings, walls, doors and trim. It is ideal for a variety of settings such as healthcare facilities, athletic facilities, schools, day care centers, senior care communities, residential housing, hospitality settings and cruise ships.
Featuring quality coating performance, great hide and durability, Paint Shield will be available in 590 colors and will come in the popular eg-shel finish. Sherwin-Williams expects Paint Shield to be available in Sherwin-Williams stores in the United States starting in the first quarter of 2016.
By killing these infectious bacteria on painted surfaces, Paint Shield offers customers an important new tool to help prevent the spread of bacteria that can cause hospital-acquired infections (HAIs). Surfaces painted with Paint Shield kill greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycin-resistant Enterococcus faecalis) and Enterobacter aerogenes after two hours of exposure.
“Paint Shield is one of the most significant technological breakthroughs in our nearly 150 year history of innovation,” said Chris Connor, chairman and chief executive, Sherwin-Williams. “By killing infectious pathogens on painted surfaces, Paint Shield is a game-changing advancement in coatings technology.”
Paint Shield doesn’t just inhibit the growth of common microbes, it actually has the power to kill infectious bacteria, including Staph (Staphylococcus aureus), MRSA, and E. coli, thereby giving healthcare systems and other facilities an important new tool to help prevent the spread of some of the most common bacteria that trigger hospital-acquired infections. EPA-test protocol showed that once it is applied, the effectiveness of Paint Shield lasts for up to four years, as long as the integrity of the surface is maintained.
According to the U.S. Department of Health and Human Services, healthcare-associated infections are one of the leading causes of preventable deaths in the United States. Further, the U.S. Centers for Disease Control and Prevention (CDC) notes that approximately one in 25 U.S. patients contract at least one infection during the course of their hospital care.
“Continued progress in combating HAIs will require a broad array of measures, including passive methods that are less dependent on human intervention,” said Steve Revnew, senior vice president of Product Innovation, Sherwin-Williams. “By continuing to kill MRSA and other bacteria, even after repeated contamination, Paint Shield offers hospitals and other facilities an important new tool to help in the fight against the spread of HAIs.”
The exclusive patented technology in Paint Shield represents the culmination of extensive research and collaboration between Sherwin-Williams coatings scientists and expert microbiologists.
Paint Shield can be applied on interior hard, non-porous ceilings, walls, doors and trim. It is ideal for a variety of settings such as healthcare facilities, athletic facilities, schools, day care centers, senior care communities, residential housing, hospitality settings and cruise ships.
Featuring quality coating performance, great hide and durability, Paint Shield will be available in 590 colors and will come in the popular eg-shel finish. Sherwin-Williams expects Paint Shield to be available in Sherwin-Williams stores in the United States starting in the first quarter of 2016.
